Retatrutide is an investigational peptide studied as a multi-receptor agonist with activity at GIP, GLP-1, and glucagon (GCG) receptors (“triple agonist”) in metabolic research contexts. It is used in non-clinical research settings to study peptide hormone receptor pharmacology and downstream signaling across incretin/glucagon pathways.